


The investment objective of the Fund is to achieve long-term capital growth through investment in a diversified portfolio of quoted equity investments principally in companies incorporated in any European country or in companies that have a significant proportion of their assets or interests in Continental Europe.
| Name | % Net Assets | 
|---|---|
| 30 Year German Bund | 16.5% | 
| France Telecom | 5.9% | 
| Koninklijke KPN | 5.7% | 
| British American Tobacco | 5.5% | 
| Imperial Tobacco | 5.5% | 
| Roche | 4.4% | 
| Deutsche Telekom | 4.3% | 
| Syngenta | 4.2% | 
| Novo Nordisk | 3.8% | 
| SES Global | 3.7% | 
| Key | % Net Assets | 
|---|---|
| 16.5% | |
| 5.9% | |
| 5.7% | |
| 5.5% | |
| 66.4% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 03/04/2006 | 
|---|---|
| Fund Manager | n/a | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | 5000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.75% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research